Brazilin inhibits the inflammatory immune response induced by LPS in THP-1 cells

Author:

Han Deting1,Ma Tao2,Sun Shanmei1,Zhang Yameng1,Song Lucheng1

Affiliation:

1. The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital

2. Jinan Zhangqiu District Hospital of TCM

Abstract

Abstract Objective To investigate the inhibitory effect of Brazilin (BN) on the inflammatory response of THP-1-derived macrophages induced by LPS. Methods THP-1 cells were induced with PMA to extend pseudopodia and form macrophages, and the inflammatory model was induced by LPS. The cell survival rate intervented by Brazilin was determined by the CCK-8 method, and the expression of PD-1 was detected by Flow cytometry, and contents of the cytokines IL-10 and TNF-α in the extracted supernatant of THP-1 cells were detected by ELISA, and the mRNA level was detected by RT‒PCR, while the protein level were detected by Western blot. Results The results showed that the best concentration of Brazilin was 12 µg/mL. The best concentration of simvastatin was 15 µg/mL, and the growth was concentration dependent. The expression of PD-1 on the cell surface in the two groups was significantly decreased compared with the control group, and the differences in the Brazilin group and the simvastatin group were significant (P < 0.01; P < 0.001; P < 0.001). The concentrations of TNF-α in the drug groups were significantly decreased while the IL-10 concentration was increased, and compared with the model group, the two drug groups were highly statistically significant (P < 0.001). The mRNA and the protein expression levels of PD-1, NF-κB, TLR4 and MMP-9 in the test groups had extremely significant difference compared with the model group (P < 0.001). Conclusion Brazilin can inhibit the abnormal activation of PD-1, TLR4, NF-κB and MMP-9 and is a good anti-AS drug that can not only reduce blood lipids but also have immunoregulatory and anti-inflammatory activity, laying a solid theoretical foundation for future screening and development of anti-AS drugs.

Publisher

Research Square Platform LLC

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3